• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

卡培他滨在 5-氟尿嘧啶/亚叶酸钙治疗后出现严重毒性。

Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin.

机构信息

Department of Medical Oncology, VU University Medical Center, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.

出版信息

Med Oncol. 2011 Dec;28(4):1136-9. doi: 10.1007/s12032-010-9598-9. Epub 2010 Jun 22.

DOI:10.1007/s12032-010-9598-9
PMID:20567941
Abstract

Colorectal carcinomas are among the most common tumor types and are generally treated with palliative chemotherapy in case of metastatic disease. Here, we describe the case of a 58 year old woman with metastatic rectal carcinoma who developed severe gastrointestinal toxicity when the thus far well-tolerated intravenous 5-fluorouracil (5-FU)/leucovorin containing chemotherapeutic regimen was replaced by the same chemotherapeutic regimen in combination with the oral 5-FU prodrug capecitabine. This increased toxicity is probably due to the intracellular retention of polyglutamated folates induced by prior leucovorin therapy which, upon subsequent administration of capecitabine, will result in an enhanced and prolonged inhibition of the, for DNA synthesis important, enzyme thymidylate synthase, essentially creating a situation equivalent to overdosing.

摘要

结直肠癌是最常见的肿瘤类型之一,一般在转移性疾病的情况下采用姑息化疗进行治疗。在这里,我们描述了一位 58 岁女性转移性直肠癌的病例,当她原本耐受良好的静脉注射氟尿嘧啶(5-FU)/亚叶酸方案更换为相同的化疗方案,同时联合应用氟尿嘧啶前体药物卡培他滨时,出现了严重的胃肠道毒性。这种毒性增加可能是由于先前亚叶酸治疗诱导的多谷氨酸化叶酸在细胞内的蓄积,随后给予卡培他滨会导致对 DNA 合成重要的酶胸苷酸合成酶的增强和延长抑制,实质上造成了相当于药物过量的情况。

相似文献

1
Severe toxicity of capecitabine following uncomplicated treatment with 5-fluorouracil/leucovorin.卡培他滨在 5-氟尿嘧啶/亚叶酸钙治疗后出现严重毒性。
Med Oncol. 2011 Dec;28(4):1136-9. doi: 10.1007/s12032-010-9598-9. Epub 2010 Jun 22.
2
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.口服卡培他滨与静脉注射氟尿嘧啶加亚叶酸钙治疗转移性结直肠癌患者的疗效比较:一项大型III期研究的结果
J Clin Oncol. 2001 Nov 1;19(21):4097-106. doi: 10.1200/JCO.2001.19.21.4097.
3
Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.单药卡培他滨用于对5-氟尿嘧啶/亚叶酸钙化疗难治的转移性结直肠癌患者。
Jpn J Clin Oncol. 2004 Jul;34(7):400-4. doi: 10.1093/jjco/hyh068.
4
Capecitabine monotherapy as salvage treatment after failure of chemotherapy containing oxaliplatin and irinotecan in patients with metastatic colorectal cancer.卡培他滨单药疗法作为含奥沙利铂和伊立替康的化疗方案失败后转移性结直肠癌患者的挽救治疗。
Asia Pac J Clin Oncol. 2011 Mar;7(1):82-7. doi: 10.1111/j.1743-7563.2010.01363.x. Epub 2010 Dec 22.
5
Capecitabine: a review of its use in the treatment of advanced or metastatic colorectal cancer.卡培他滨:其用于治疗晚期或转移性结直肠癌的综述
Drugs. 2001;61(15):2309-26. doi: 10.2165/00003495-200161150-00015.
6
First-line oral capecitabine therapy in metastatic colorectal cancer: a favorable safety profile compared with intravenous 5-fluorouracil/leucovorin.转移性结直肠癌的一线口服卡培他滨治疗:与静脉注射氟尿嘧啶/亚叶酸相比,具有良好的安全性。
Ann Oncol. 2002 Apr;13(4):566-75. doi: 10.1093/annonc/mdf089.
7
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.口服卡培他滨与静脉注射氟尿嘧啶加亚叶酸钙作为605例转移性结直肠癌患者一线治疗的比较:一项随机III期研究的结果
J Clin Oncol. 2001 Apr 15;19(8):2282-92. doi: 10.1200/JCO.2001.19.8.2282.
8
A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer.一项随机交叉试验,比较晚期结直肠癌患者对口服卡培他滨和5-氟尿嘧啶/亚叶酸钙方案的偏好。
Ann Oncol. 2006 Feb;17(2):239-45. doi: 10.1093/annonc/mdj023. Epub 2005 Dec 12.
9
[Severe toxicity following capecitabine administration because of dihydropyrimidine deshydrogenase (DPD) deficiency].[因二氢嘧啶脱氢酶(DPD)缺乏导致卡培他滨给药后出现严重毒性反应]
Gastroenterol Clin Biol. 2010 Mar;34(3):218-23. doi: 10.1016/j.gcb.2009.08.014. Epub 2010 Mar 10.
10
Health-related quality of life and cost comparison of adjuvant capecitabine versus 5-fluorouracil/leucovorin in stage III colorectal cancer patients.III期结直肠癌患者中辅助性卡培他滨与5-氟尿嘧啶/亚叶酸钙的健康相关生活质量及成本比较
Qual Life Res. 2015 Feb;24(2):473-84. doi: 10.1007/s11136-014-0773-x. Epub 2014 Aug 7.

引用本文的文献

1
Colon Cancer Pharmacogenetics: A Narrative Review.结肠癌药物遗传学:一篇叙述性综述。
Pharmacy (Basel). 2022 Aug 5;10(4):95. doi: 10.3390/pharmacy10040095.
2
Effect of onion flavonoids on colorectal cancer with hyperlipidemia: an in vivo study.洋葱类黄酮对高脂血症结直肠癌的影响:一项体内研究。
Onco Targets Ther. 2014 Jan 8;7:101-10. doi: 10.2147/OTT.S51835. eCollection 2014.

本文引用的文献

1
Severe sequence-specific toxicity when capecitabine is given after Fluorouracil and leucovorin.在氟尿嘧啶和亚叶酸钙之后给予卡培他滨时,会出现严重的序列特异性毒性。
J Clin Oncol. 2008 Jul 10;26(20):3411-7. doi: 10.1200/JCO.2007.15.9426.
2
Randomized phase III study of capecitabine plus oxaliplatin compared with fluorouracil/folinic acid plus oxaliplatin as first-line therapy for metastatic colorectal cancer.卡培他滨联合奥沙利铂与氟尿嘧啶/亚叶酸钙联合奥沙利铂作为转移性结直肠癌一线治疗的随机III期研究。
J Clin Oncol. 2008 Apr 20;26(12):2006-12. doi: 10.1200/JCO.2007.14.9898.
3
[Chemotherapy of patients with colorectal carcinoma].
[结直肠癌患者的化疗]
Ned Tijdschr Geneeskd. 2005 Jun 25;149(26):1441-7.
4
Capecitabine: a review.卡培他滨:综述
Clin Ther. 2005 Jan;27(1):23-44. doi: 10.1016/j.clinthera.2005.01.005.
5
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer.贝伐单抗联合伊立替康、氟尿嘧啶和亚叶酸钙治疗转移性结直肠癌。
N Engl J Med. 2004 Jun 3;350(23):2335-42. doi: 10.1056/NEJMoa032691.
6
5-fluorouracil: mechanisms of action and clinical strategies.5-氟尿嘧啶:作用机制与临床策略
Nat Rev Cancer. 2003 May;3(5):330-8. doi: 10.1038/nrc1074.
7
Effect of renal impairment on the pharmacokinetics and tolerability of capecitabine (Xeloda) in cancer patients.肾功能损害对卡培他滨(希罗达)在癌症患者体内药代动力学及耐受性的影响。
Cancer Chemother Pharmacol. 2002 Mar;49(3):225-34. doi: 10.1007/s00280-001-0408-0. Epub 2002 Jan 10.
8
Oral capecitabine compared with intravenous fluorouracil plus leucovorin in patients with metastatic colorectal cancer: results of a large phase III study.口服卡培他滨与静脉注射氟尿嘧啶加亚叶酸钙治疗转移性结直肠癌患者的疗效比较:一项大型III期研究的结果
J Clin Oncol. 2001 Nov 1;19(21):4097-106. doi: 10.1200/JCO.2001.19.21.4097.
9
Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.口服卡培他滨与静脉注射氟尿嘧啶加亚叶酸钙作为605例转移性结直肠癌患者一线治疗的比较:一项随机III期研究的结果
J Clin Oncol. 2001 Apr 15;19(8):2282-92. doi: 10.1200/JCO.2001.19.8.2282.
10
A Phase I study of capecitabine in combination with oral leucovorin in patients with intractable solid tumors.
Clin Cancer Res. 1998 Nov;4(11):2755-61.